The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


CEVAC TRANSMUNE lyophilisate for suspension for injection with solvent for chickens

. Lyophilisate and solvent for suspension for injection

Ceva Santé AnimaleVPA10815/005/001

Main Information

Trade NameCEVAC TRANSMUNE lyophilisate for suspension for injection with solvent for chickens
Active SubstancesLive, attenuated infectious bursal disease (IBD) virus, strain winterfield 2512, G-61
Strength.
Dosage FormLyophilisate and solvent for suspension for injection
Licence HolderCeva Santé Animale
Licence NumberVPA10815/005/001

Group Information

ATC CodeQI01AD09 avian infectious bursal disease virus (gumboro disease)
Therapeutic ClassImmunological
SpeciesChickens

Status

Authorised/WithdrawnAuthorised
Licence Issued26/11/2007
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back